Since establishing our private equity strategy in 1989, we have invested in over 415 private equity investments in 42 countries.
| Company | Country | Sector | Description | Deal type | Invest. date | |
|---|---|---|---|---|---|---|
 |
3i - Implant Innovations Inc.
|
Country United States | Sector Healthcare | Description Manufacturer of dental implants | Deal type Growth equity | Invest. date May 1995 |
 |
Alcala Farma
|
Country Spain | Sector Healthcare | Description Manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and over-the-counter products | Deal type Growth equity | Invest. date Sep 1999 |
 |
Aviagen
|
Country United Kingdom | Sector Healthcare | Description World's leading meat poultry breeding company | Deal type Buyout | Invest. date May 2003 |
 |
BioDuro
|
Country China | Sector Healthcare | Description A leading global life sciences contract research and development organization | Deal type Buyout | Invest. date Jan 2019 |
 |
Esaote Biomedica
|
Country Italy | Sector Healthcare | Description Research, production and marketing of imaging and non-imaging medical diagnostic equipment | Deal type Privatization | Invest. date Jul 1994 |
 |
Fada Pharma
|
Country Argentina | Sector Healthcare | Description Argentina's leading manufacturer of generic pharmaceuticals for the institutional market | Deal type Buyout | Invest. date Jan 2001 |
 |
Genoa Healthcare
|
Country United States | Sector Healthcare | Description Largest specialty pharmacy operator in the US focusing primarily on serving the needs of the mental health community | Deal type Buyout | Invest. date Apr 2015 |
 |
Grupo Biotoscana
|
Country Colombia | Sector Healthcare | Description Specialty pharmaceutical company licensing innovative and niche products to market in Latin America | Deal type Buyout | Invest. date Nov 2011 |
 |
ICE Pharma
|
Country Italy | Sector Healthcare | Description A global leader in the production of Ursodeoxycholic Acid (UDCA) used for the treatment of gastric and chronic diseases | Deal type Buyout | Invest. date Sep 2019 |
 |
Laboratorio LKM
|
Country Argentina | Sector Healthcare | Description One of the leading specialty pharmaceutical manufacturers in Argentina | Deal type Buyout | Invest. date Oct 2011 |
 |
Labormed
|
Country Romania | Sector Healthcare | Description Romanian pharmaceutical manufacturer and distributor | Deal type Buyout | Invest. date Feb 2008 |
 |
Mediq
|
Country Netherlands | Sector Healthcare | Description Global provider of pharmaceuticals, medical devices and related care services | Deal type Public-to-private | Invest. date Feb 2013 |
 |
Simtra BioPharma Solutions
|
Country United States | Sector Healthcare | Description Leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharmaceutical and biotech industries | Deal type Carve-out | Invest. date Sep 2023 |
 |
Suven Pharmaceuticals
|
Country India | Sector Healthcare | Description A leader in the India pharma CDMO space | Deal type Other | Invest. date Sep 2023 |
 |
Telik
|
Country United States | Sector Healthcare | Description Developer of novel pharmaceuticals to treat cancer and metabolic diseases (merged with MabVax Therapeutics) | Deal type Growth equity | Invest. date Nov 1994 |
 |
Terapia
|
Country Romania | Sector Healthcare | Description Romania's largest independent generic pharmaceuticals manufacturer | Deal type Public-to-private | Invest. date Aug 2003 |
 |
Transcend Therapeutics
|
Country United States | Sector Healthcare | Description Company formed to develop novel pharmaceuticals for the critical-care market | Deal type Growth equity | Invest. date Apr 1994 |
 |
Trinity Pharmaceuticals
|
Country United Kingdom | Sector Healthcare | Description Co-development, licensing and marketing of branded pharmaceuticals, mainly for cardiovascular and arthritic indications | Deal type Carve-out | Invest. date Mar 1997 |
 |
Tropon
|
Country Germany | Sector Healthcare | Description Toll manufacturer and supplier of drugs for inflammatory and rheumatoid disorders (acquired by Advent portfolio company Viatris) | Deal type Carve-out | Invest. date Mar 2000 |
 |
Viatris
|
Country Germany | Sector Healthcare | Description Development, manufacturing, distribution and in-licensing of branded pharmaceuticals | Deal type Carve-out | Invest. date Aug 2002 |
 |
Zentiva
|
Country Czech Republic | Sector Healthcare | Description A leading European generics pharmaceutical company, offering generic medicines across all key therapeutic areas | Deal type Carve-out | Invest. date Sep 2018 |
© 2002-2024 Advent International, L.P. All rights reserved
